Connect your AI

Evolus EOLS Total Current Liabilities

Total Current Liabilities at other companies

AbbVieABBV

$42.1B+15.6%

Other financials

Income statement

Revenue$73.1M+6.7%

Gross profit$48.9M+4.8%

Operating income-$6.8M+54.9%

Net income-$10.7M+43.5%

EPS (diluted)-$0.16+46.7%

Balance sheet

Cash & equivalents$49.8M-26.7%

Total debt$164.9M-4.1%

Total equity-$28.8M-336%

Total assets$220.6M+3.4%

Cash flow

Operating cash flow-$10.0M+36.3%

CapEx$415.0K+30.1%

Free cash flow-$10.4M+35.0%

Valuation

Market cap$470.86M-21.3%

Enterprise value$585.97M-16.6%

P/S1.6×-0.6×

Profitability

Gross margin66.1%-2.4pp

Operating margin-13.7%-1.9pp

Net margin-14.4%-3.3pp

FCF margin-9.6%-3.6pp

Returns & leverage

Return on equity-472.6%-1,534pp

Debt / equity22.2×—

Current ratio2×-0.3×

Where this comes from

Reported directly by Evolus in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.

The official record: Evolus’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Evolus's total current liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Evolus's total current liabilities?: Evolus (EOLS) reported total current liabilities of $68.02M in Q1 2026.
How has Evolus's total current liabilities changed year-over-year?: Evolus's total current liabilities increased by 21.0% year-over-year, from $56.23M to $68.02M.
What is the long-term trend for Evolus's total current liabilities?: Over 5 years (2020 to 2025), Evolus's total current liabilities has grown at a -16.0% compound annual growth rate (CAGR), from $180.25M to $75.31M.
What does total current liabilities mean?: The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.